Facade Sandwich Panels
Facade Sandwich Panels market is segmented by Type and by Application. Players, stakeholders, and ... Read More
Global Intravenous Immunoglobulin (IVIg) Market Insights and Forecast to 2028
1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts 2017-2028
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Estimates and Forecasts 2017-2028
2.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intravenous Immunoglobulin (IVIg) Sales by Region
2.4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022)
2.4.2 Global Sales Intravenous Immunoglobulin (IVIg) by Region (2023-2028)
2.5 Global Intravenous Immunoglobulin (IVIg) Revenue by Region
2.5.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022)
2.5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
3.1.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales (2017-2022)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Immunoglobulin (IVIg) in 2021
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2017-2022)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Revenue in 2021
3.3 Global Intravenous Immunoglobulin (IVIg) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intravenous Immunoglobulin (IVIg) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type
4.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Type (2017-2022)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Type (2023-2028)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
4.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Type (2017-2022)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type
4.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Type (2017-2022)
4.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application
5.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Application (2017-2022)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Application (2023-2028)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application
5.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Application (2017-2022)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application
5.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Application (2017-2022)
5.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Type
6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
6.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Application
6.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
6.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
6.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
6.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
7.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application
7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
7.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
7.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
7.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
7.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Type
8.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
8.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Application
8.2.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
8.2.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region
8.3.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2028)
8.3.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Type
9.1.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
9.1.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
9.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Application
9.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
9.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
9.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country
9.3.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
9.3.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Type
10.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2028)
10.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Application
10.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2028)
10.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
10.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Corporation Information
11.5.2 Biotest Overview
11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biotest Recent Developments
11.6 Kedrion
11.6.1 Kedrion Corporation Information
11.6.2 Kedrion Overview
11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kedrion Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Corporation Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Overview
11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Corporation Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Overview
11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 LFB Group
11.11.1 LFB Group Corporation Information
11.11.2 LFB Group Overview
11.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 LFB Group Recent Developments
11.12 BPL
11.12.1 BPL Corporation Information
11.12.2 BPL Overview
11.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BPL Recent Developments
11.13 Sichuan Yuanda Shuyang
11.13.1 Sichuan Yuanda Shuyang Corporation Information
11.13.2 Sichuan Yuanda Shuyang Overview
11.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sichuan Yuanda Shuyang Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
12.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
12.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
12.4.2 Intravenous Immunoglobulin (IVIg) Distributors
12.5 Intravenous Immunoglobulin (IVIg) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intravenous Immunoglobulin (IVIg) Industry Trends
13.2 Intravenous Immunoglobulin (IVIg) Market Drivers
13.3 Intravenous Immunoglobulin (IVIg) Market Challenges
13.4 Intravenous Immunoglobulin (IVIg) Market Restraints
14 Key Findings in The Global Intravenous Immunoglobulin (IVIg) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of IVIg Liquid
Table 3. Major Manufacturers of IVIg Powder
Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022) & (K Bottle)
Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2017-2022)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2023-2028) & (K Bottle)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2023-2028)
Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2017-2022)
Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2023-2028)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2017-2022) & (K Bottle)
Table 15. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2017-2022)
Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2017-2022)
Table 18. Intravenous Immunoglobulin (IVIg) Price by Manufacturers (2017-2022) &(USD/Bottle)
Table 19. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2021)
Table 21. Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Intravenous Immunoglobulin (IVIg) Product Offered
Table 23. Date of Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 26. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
Table 27. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2017-2022)
Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2023-2028)
Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2017-2022)
Table 32. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2023-2028)
Table 33. Intravenous Immunoglobulin (IVIg) Price by Type (2017-2022) & (USD/Bottle)
Table 34. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2023-2028) & (USD/Bottle)
Table 35. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2017-2022)
Table 38. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2023-2028)
Table 39. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2017-2022)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2023-2028)
Table 43. Intravenous Immunoglobulin (IVIg) Price by Application (2017-2022) & (USD/Bottle)
Table 44. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2023-2028) & (USD/Bottle)
Table 45. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 46. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
Table 47. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 50. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
Table 51. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 54. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
Table 55. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 58. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
Table 59. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 62. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
Table 63. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 66. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
Table 67. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 70. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
Table 71. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 74. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
Table 75. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2017-2022) & (K Bottle)
Table 78. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2023-2028) & (K Bottle)
Table 79. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 82. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
Table 83. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 86. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
Table 87. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 90. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
Table 91. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2022) & (K Bottle)
Table 94. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2023-2028) & (K Bottle)
Table 95. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2022) & (K Bottle)
Table 98. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2023-2028) & (K Bottle)
Table 99. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2022) & (K Bottle)
Table 102. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2023-2028) & (K Bottle)
Table 103. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2023-2028) & (US$ Million)
Table 105. Baxter Corporation Information
Table 106. Baxter Description and Major Businesses
Table 107. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 108. Baxter Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Baxter Recent Developments
Table 110. Grifols Corporation Information
Table 111. Grifols Description and Major Businesses
Table 112. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 113. Grifols Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Grifols Recent Developments
Table 115. CSL Corporation Information
Table 116. CSL Description and Major Businesses
Table 117. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 118. CSL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. CSL Recent Developments
Table 120. Octapharma Corporation Information
Table 121. Octapharma Description and Major Businesses
Table 122. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 123. Octapharma Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Octapharma Recent Developments
Table 125. Biotest Corporation Information
Table 126. Biotest Description and Major Businesses
Table 127. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 128. Biotest Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biotest Recent Developments
Table 130. Kedrion Corporation Information
Table 131. Kedrion Description and Major Businesses
Table 132. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 133. Kedrion Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Kedrion Recent Developments
Table 135. Hualan Bio Corporation Information
Table 136. Hualan Bio Description and Major Businesses
Table 137. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 138. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Hualan Bio Recent Developments
Table 140. CNBG Corporation Information
Table 141. CNBG Description and Major Businesses
Table 142. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 143. CNBG Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. CNBG Recent Developments
Table 145. Shanghai RAAS Corporation Information
Table 146. Shanghai RAAS Description and Major Businesses
Table 147. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 148. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Shanghai RAAS Recent Developments
Table 150. CBPO Corporation Information
Table 151. CBPO Description and Major Businesses
Table 152. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 153. CBPO Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. CBPO Recent Developments
Table 155. LFB Group Corporation Information
Table 156. LFB Group Description and Major Businesses
Table 157. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 158. LFB Group Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. LFB Group Recent Developments
Table 160. BPL Corporation Information
Table 161. BPL Description and Major Businesses
Table 162. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 163. BPL Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. BPL Recent Developments
Table 165. Sichuan Yuanda Shuyang Corporation Information
Table 166. Sichuan Yuanda Shuyang Description and Major Businesses
Table 167. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
Table 168. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Sichuan Yuanda Shuyang Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Intravenous Immunoglobulin (IVIg) Distributors List
Table 173. Intravenous Immunoglobulin (IVIg) Customers List
Table 174. Intravenous Immunoglobulin (IVIg) Market Trends
Table 175. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 176. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 177. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Share by Type in 2021 & 2028
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2021 & 2028
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales 2017-2028 (K Bottle)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue 2017-2028 (US$ Million)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2017-2022)
Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2023-2028)
Figure 16. North America Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
Figure 17. North America Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
Figure 19. Europe Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
Figure 21. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
Figure 23. Latin America Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales YoY (2017-2028) & (K Bottle)
Figure 25. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Intravenous Immunoglobulin (IVIg) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Intravenous Immunoglobulin (IVIg) in the World: Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2021
Figure 28. Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
Figure 31. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
Figure 32. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
Figure 33. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
Figure 34. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
Figure 35. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
Figure 36. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
Figure 37. North America Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
Figure 38. North America Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
Figure 39. U.S. Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
Figure 42. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
Figure 43. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
Figure 44. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
Figure 45. Europe Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
Figure 46. Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
Figure 47. Germany Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 48. France Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2017-2028)
Figure 58. China Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 61. India Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
Figure 68. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
Figure 70. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
Figure 72. Latin America Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
Figure 73. Mexico Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2017-2028)
Figure 82. Turkey Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Intravenous Immunoglobulin (IVIg) Revenue (2017-2028) & (US$ Million)
Figure 85. Intravenous Immunoglobulin (IVIg) Value Chain
Figure 86. Intravenous Immunoglobulin (IVIg) Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxter Grifols CSL Octapharma Biotest Kedrion Hualan Bio CNBG Shanghai RAAS CBPO LFB Group BPL Sichuan Yuanda Shuyang